NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO
The board of directors of BHG has, as indicated in the Company’s press release earlier today, resolved on a directed new issue of 39,024,390 shares, at a subscription price of
The purpose of the Share Issue is to increase financial flexibility to support future growth initiatives and strengthen the Company’s financial position by reducing net debt. In the Company’s interim report for the third quarter 2022, it was communicated that BHG expects a challenging market environment over the next 12–18 months. The Company preliminarily believes that the order intake for the period October–November 2022 including Black Week has developed broadly in line with the organic sales development in the third quarter 2022. Going forward BHG remains committed to leverage its market leading positions with a strong focus on profitability and cash flows.
The board of directors has carefully considered the option to carry out a rights issue in order to raise the requisite proceeds. In the evaluation, the board of directors has considered, among other things, the following factors: a rights issue, compared to the Share Issue (i) would be significantly more time consuming, which would lead to risks that the Company loses potential growth opportunities, (ii) would entail higher total costs for the Company, mainly due to procurement of a guarantee consortium, (iii) would expose the Company to market volatility, especially considering current market conditions, and (iv) likely would have had to be made at a lower subscription price, to the disadvantage of all the Company’s shareholders. In addition, the board of directors considers it positive that the Company’s shareholder base, through the Share Issue, will be further diversified with Swedish and international institutional investors, which is also considered to be positive for the share’s liquidity. Against this background, the board of directors’ overall assessment is that the reasons for carrying out the Share Issue in this manner overweigh, in this particular case, the principal rule that new share issues shall be carried out with pre-emptive rights for existing shareholders, and that a new share issue with deviation from the shareholders’ pre-emptive rights is in the interest of the Company and all shareholders.
To ensure that the Share Issue was carried out at market terms, the board of directors appointed Carnegie,
Investors in the Share Issue were a large number of Swedish and international institutional investors. In addition, as earlier communicated, the Company’s largest shareholders EQT, Ferd and Vitruvian participated in the Share Issue with a significant amount.
The Share Issue entails a dilution of approximately 21.8 percent of the number of shares and votes in BHG. The number of shares and votes in BHG will thereby increase by 39,024,390, from 140,209,173 to 179,233,563. The share capital in the Company will increase by
The Company has, in favour of Carnegie,
Part of the Share Issue resolved upon by the board of directors on the basis of the authorisation will be settled at a later stage, once a prospectus for admission to trading of shares in BHG has been approved by the
Extraordinary general meeting
An extraordinary general meeting will be convened to approve the part of the Share Issue which is not based on the annual general meeting’s issue authorisation. Some of the Company’s existing shareholders, including EQT, Ferd and Vitruvian, together holding approximately 45 percent of the shares and votes in BHG, have expressed their intention to vote in favour thereof at the extraordinary general meeting. A separate notice to the extraordinary general meeting will be published within short.
Advisers
Carnegie,
© Modular Finance, source